2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid has been researched along with phenobarbital in 1 studies
Studies (2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid) | Trials (2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid) | Recent Studies (post-2010) (2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid) | Studies (phenobarbital) | Trials (phenobarbital) | Recent Studies (post-2010) (phenobarbital) |
---|---|---|---|---|---|
111 | 0 | 9 | 18,336 | 619 | 1,117 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanimura, A; Turner, RJ | 1 |
1 other study(ies) available for 2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid and phenobarbital
Article | Year |
---|---|
Calcium release in HSY cells conforms to a steady-state mechanism involving regulation of the inositol 1,4,5-trisphosphate receptor Ca2+ channel by luminal [Ca2+].
Topics: Calcium; Calcium Channels; Cell Line; Fluorescent Dyes; Fura-2; Humans; Hypnotics and Sedatives; Inositol 1,4,5-Trisphosphate Receptors; Ion Channel Gating; Phenobarbital; Receptors, Cytoplasmic and Nuclear | 1996 |